We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Docusign Stock Gains 32% in a Year: Time to Buy, Sell or Hold?
Read MoreHide Full Article
Docusign, Inc. (DOCU - Free Report) shares have gained 31.6% in a year, outperforming the 7.6% rise of its industry and the 9.3% rally in the Zacks S&P 500 Composite.
OPFI performed significantly better than its industry peers, StoneCo Ltd. (STNE - Free Report) and Thryv Holdings, Inc. (THRY - Free Report) . STNE and THRY shares have declined 22.4% and 47.5% in a year.
One-Year Price Performance
Image Source: Zacks Investment Research
Docusign has also outperformed its industry and Thryv Holdings but underperformed StoneCo in the past six months. DOCU shares have gained 5.7% against the industry’s and Thryv Holdings’ 5.4% and 33.3% declines, respectively. Meanwhile, Docusign has underperformed StoneCo’s 7.4% growth.
In the last trading session, the DOCU stock closed at $76.39, moving down 41.2% from the 52-week high of $107.86.
While DOCU’s one-year gain might appeal to investors, is it the right time to buy the stock, hold or sell it? Let us analyze it further.
Promising Growth Potential From Docusign’s IAM
DOCU launched Intelligent Agreement Management (IAM) — an AI-powered platform that assists customers in creating, analyzing, managing and automating agreements throughout their lifecycle. IAM lowers manual efforts, fast-paced execution, and assist organizations in gaining greater visibility and control over their agreement data.
Despite being in the early phase, the product has a high adoption rate. In the fourth quarter of fiscal 2025, management included IAM in a high-single-digit percentage of all deals and contributed more than 20% of direct sales. More importantly, management anticipates the product to generate a low-double-digit percentage proportion of the recurring subscription revenue base by the fourth quarter of fiscal 2026.
Per management, IAM is the fastest-growing new product in DOCU’s history. We anticipate the momentum of this product to grow further.
DOCU’s Enterprise Expansion Back on Track
In the fourth quarter of fiscal 2025, the company added 56 customers with annual contract value (ACV) surpassing the $300,000 mark, bringing the total to 1,131. This is a significant improvement from the preceding quarter’s nine additions. This rebound hints at the efficacy of IAM, which assists DOCU in landing new large accounts and has the potential to lock in higher ACV. Continued momentum is likely to grow the deal volume exponentially and boost the top line.
Docusign’s Robust Capital Returns
Return on equity (ROE), a measure of profitability, reflects how effectively a company uses its shareholders' investments to generate earnings. DOCU’s trailing 12-month ROE is 42.2% compared with the industry’s average of 31.7%.
Image Source: Zacks Investment Research
DOCU’s Top-Line Prospects Strong, Bottom Line Weak
The Zacks Consensus Estimate for Docusign’s fiscal 2026 revenues is pegged at $3.1 billion, implying 5.3% year-over-year growth. The consensus estimate for OPFI’s 2025 earnings per share stands at $3.47, suggesting a 2.3% year-over-year decrease.
IAM Monetization Might Hinder Docusign
Despite showing promising results, one must keep in mind that IAM is still new in the market, raising questions about IAM adoption at scale, especially as monetization is early. If DOCU ramps up monetization, it might hurt adoption, thereby limiting the growth potential.
Considering the turbulent macroeconomic situation, if a recession sets in, we might find businesses pull back or shy away from tech investments. This will either slow down or delay Docusign’s growth.
DOCU’s Liquidity Position Lags Industry
In the fourth quarter of fiscal 2025, DOCU’s current ratio registered at 0.81, lower than the industry average of 2.54. This metric declined from the preceding quarter’s 0.83 and the year-ago quarter’s 0.94. The decrease is primarily attributed to a significant rise in short-term debt, hinting at a troubled liquidity position. A current ratio of less than 1 is an added concern about DOCU’s liquidity status, suggesting an inability to pay short-term debts efficiently.
Image Source: Zacks Investment Research
Final Verdict: Hold Docusign’s Stock
We are impressed with the momentum that Docusign’s IAM has gained and expect it to bring more customers with higher ACV, boosting the top line. Investors may find DOCU’s strong capital returns appealing. These positives cannot shadow the fact that despite having a strong top-line prospect, the bottom-line outlook looks troublesome. Furthermore, the probability of IAM’s heightened monetization, coupled with a weak liquidity position, paints a dull picture of the company.
Keeping aside these pros and cons, DOCU shares have declined 10.1% in a month, indicating that it is currently riding the correction phase. This trend compels us to recommend that investors take a cautious approach, stay put and watch for further adjustments in share prices before buying.
Image: Bigstock
Docusign Stock Gains 32% in a Year: Time to Buy, Sell or Hold?
Docusign, Inc. (DOCU - Free Report) shares have gained 31.6% in a year, outperforming the 7.6% rise of its industry and the 9.3% rally in the Zacks S&P 500 Composite.
OPFI performed significantly better than its industry peers, StoneCo Ltd. (STNE - Free Report) and Thryv Holdings, Inc. (THRY - Free Report) . STNE and THRY shares have declined 22.4% and 47.5% in a year.
One-Year Price Performance
Docusign has also outperformed its industry and Thryv Holdings but underperformed StoneCo in the past six months. DOCU shares have gained 5.7% against the industry’s and Thryv Holdings’ 5.4% and 33.3% declines, respectively. Meanwhile, Docusign has underperformed StoneCo’s 7.4% growth.
In the last trading session, the DOCU stock closed at $76.39, moving down 41.2% from the 52-week high of $107.86.
While DOCU’s one-year gain might appeal to investors, is it the right time to buy the stock, hold or sell it? Let us analyze it further.
Promising Growth Potential From Docusign’s IAM
DOCU launched Intelligent Agreement Management (IAM) — an AI-powered platform that assists customers in creating, analyzing, managing and automating agreements throughout their lifecycle. IAM lowers manual efforts, fast-paced execution, and assist organizations in gaining greater visibility and control over their agreement data.
Despite being in the early phase, the product has a high adoption rate. In the fourth quarter of fiscal 2025, management included IAM in a high-single-digit percentage of all deals and contributed more than 20% of direct sales. More importantly, management anticipates the product to generate a low-double-digit percentage proportion of the recurring subscription revenue base by the fourth quarter of fiscal 2026.
Per management, IAM is the fastest-growing new product in DOCU’s history. We anticipate the momentum of this product to grow further.
DOCU’s Enterprise Expansion Back on Track
In the fourth quarter of fiscal 2025, the company added 56 customers with annual contract value (ACV) surpassing the $300,000 mark, bringing the total to 1,131. This is a significant improvement from the preceding quarter’s nine additions. This rebound hints at the efficacy of IAM, which assists DOCU in landing new large accounts and has the potential to lock in higher ACV. Continued momentum is likely to grow the deal volume exponentially and boost the top line.
Docusign’s Robust Capital Returns
Return on equity (ROE), a measure of profitability, reflects how effectively a company uses its shareholders' investments to generate earnings. DOCU’s trailing 12-month ROE is 42.2% compared with the industry’s average of 31.7%.
DOCU’s Top-Line Prospects Strong, Bottom Line Weak
The Zacks Consensus Estimate for Docusign’s fiscal 2026 revenues is pegged at $3.1 billion, implying 5.3% year-over-year growth. The consensus estimate for OPFI’s 2025 earnings per share stands at $3.47, suggesting a 2.3% year-over-year decrease.
IAM Monetization Might Hinder Docusign
Despite showing promising results, one must keep in mind that IAM is still new in the market, raising questions about IAM adoption at scale, especially as monetization is early. If DOCU ramps up monetization, it might hurt adoption, thereby limiting the growth potential.
Considering the turbulent macroeconomic situation, if a recession sets in, we might find businesses pull back or shy away from tech investments. This will either slow down or delay Docusign’s growth.
DOCU’s Liquidity Position Lags Industry
In the fourth quarter of fiscal 2025, DOCU’s current ratio registered at 0.81, lower than the industry average of 2.54. This metric declined from the preceding quarter’s 0.83 and the year-ago quarter’s 0.94. The decrease is primarily attributed to a significant rise in short-term debt, hinting at a troubled liquidity position. A current ratio of less than 1 is an added concern about DOCU’s liquidity status, suggesting an inability to pay short-term debts efficiently.
Final Verdict: Hold Docusign’s Stock
We are impressed with the momentum that Docusign’s IAM has gained and expect it to bring more customers with higher ACV, boosting the top line. Investors may find DOCU’s strong capital returns appealing. These positives cannot shadow the fact that despite having a strong top-line prospect, the bottom-line outlook looks troublesome. Furthermore, the probability of IAM’s heightened monetization, coupled with a weak liquidity position, paints a dull picture of the company.
Keeping aside these pros and cons, DOCU shares have declined 10.1% in a month, indicating that it is currently riding the correction phase. This trend compels us to recommend that investors take a cautious approach, stay put and watch for further adjustments in share prices before buying.
DOCU has a Zacks Rank #3 (Hold) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.